Changed constitution without change in brand name – The risk of generics in epilepsy

Compulsory Generic Switching of Antiepileptic Drugs: High Switchback Rates to Branded Compounds Compared with Other Drug Classes

Frédérick Andermann, Mei Sheng Duh, Antoine Gosselin et al. · Epilepsia · 2007 · 178 citations

Medicine, Pharmacology, Pharmacotherapy +17

Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service

Raymond G. Morris, Andrew Black, A. Harris et al. · British Journal of Clinical Pharmacology · 1998 · 143 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +15

Generic substitution in the treatment of epilepsy

Michel J. Berg, Robert A. Gross, Kenneth J. Tomaszewski et al. · Neurology · 2008 · 133 citations

Medicine, Pharmacology, Pharmacotherapy +13

Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications

Matthew D. Krasowski · Pharmaceuticals · 2010 · 123 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Clinical consequences of generic substitution of lamotrigine for patients with epilepsy

Jacques LeLorier, Mei Sheng Duh, Pierre Emmanuel Paradis et al. · Neurology · 2008 · 117 citations

Medicine, Pharmacology, Pharmacotherapy +17